Knygos.lt klubas Knygos.lt nariams
60,19 €
-30%
Įprastai
85,99 €
Code of Federal Regulations Title 21, Volume 4, April 1, 2015
Code of Federal Regulations Title 21, Volume 4, April 1, 2015
Knygos.lt klubas Knygos.lt nariams
60,19 €
-30%
Įprastai
85,99 €
  • Išsiųsime per 12–18 d.d.
21 CFR Parts 200-299 covers prescription drug products for human use, manufacturing, labeling, processing, and packing practices, official drug names, and more.Code of Federal Regulations Title 21, Volume 4, April 1, 2015Containing parts Parts 200 to 299Part 200; GENERALPart 201; LABELINGPart 202; PRESCRIPTION DRUG ADVERTISINGPart 203; PRESCRIPTION DRUG MARKETINGPart 205; GUIDELINES FOR STATE LICENSING OF WHOLESALE PRESCRIPTION DRUG DISTRIBUTORSPart 206; IMPRINTING OF SOLID ORAL DOSAGE FORM DRU…
  • Leidėjas:
  • ISBN-10: 1354240197
  • ISBN-13: 9781354240199
  • Formatas: 15.6 x 23.4 x 1.4 cm, minkšti viršeliai
  • Kalba: Anglų

Code of Federal Regulations Title 21, Volume 4, April 1, 2015 (el. knyga) (skaityta knyga) | knygos.lt

Atsiliepimai

Aprašymas

21 CFR Parts 200-299 covers prescription drug products for human use, manufacturing, labeling, processing, and packing practices, official drug names, and more.

Code of Federal Regulations Title 21, Volume 4, April 1, 2015

Containing parts Parts 200 to 299

Part 200; GENERAL
Part 201; LABELING
Part 202; PRESCRIPTION DRUG ADVERTISING
Part 203; PRESCRIPTION DRUG MARKETING
Part 205; GUIDELINES FOR STATE LICENSING OF WHOLESALE PRESCRIPTION DRUG DISTRIBUTORS
Part 206; IMPRINTING OF SOLID ORAL DOSAGE FORM DRUG PRODUCTS FOR HUMAN USE
Part 207; REGISTRATION OF PRODUCERS OF DRUGS AND LISTING OF DRUGS IN COMMERCIAL DISTRIBUTION
Part 208; MEDICATION GUIDES FOR PRESCRIPTION DRUG PRODUCTS
Part 209; REQUIREMENT FOR AUTHORIZED DISPENSERS AND PHARMACIES TO DISTRIBUTE A SIDE EFFECTS STATEMENT
Part 210; CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PROCESSING, PACKING, OR HOLDING OF DRUGS; GENERAL
Part 211; CURRENT GOOD MANUFACTURING PRACTICE FOR FINISHED PHARMACEUTICALS
Part 212; CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS
Part 216; PHARMACY COMPOUNDING
Part 225; CURRENT GOOD MANUFACTURING PRACTICE FOR MEDICATED FEEDS
Part 226; CURRENT GOOD MANUFACTURING PRACTICE FOR TYPE A MEDICATED ARTICLES
Part 250; SPECIAL REQUIREMENTS FOR SPECIFIC HUMAN DRUGS
Part 290; CONTROLLED DRUGS
Part 299; DRUGS; OFFICIAL NAMES AND ESTABLISHED NAMES

Knygos.lt klubas
Knygos.lt nariams
60,19 €
-30%
Įprastai
85,99 €
Kaina registruotiems pirkėjams
Prisijunkite ir už šią prekę
gausite 0,86 Knygų Eurų!?
Išsiųsime per 12–18 d.d.
Įsigykite dovanų kuponą
Daugiau
  • Leidėjas:
  • ISBN-10: 1354240197
  • ISBN-13: 9781354240199
  • Formatas: 15.6 x 23.4 x 1.4 cm, minkšti viršeliai
  • Kalba: Anglų

21 CFR Parts 200-299 covers prescription drug products for human use, manufacturing, labeling, processing, and packing practices, official drug names, and more.

Code of Federal Regulations Title 21, Volume 4, April 1, 2015

Containing parts Parts 200 to 299

Part 200; GENERAL
Part 201; LABELING
Part 202; PRESCRIPTION DRUG ADVERTISING
Part 203; PRESCRIPTION DRUG MARKETING
Part 205; GUIDELINES FOR STATE LICENSING OF WHOLESALE PRESCRIPTION DRUG DISTRIBUTORS
Part 206; IMPRINTING OF SOLID ORAL DOSAGE FORM DRUG PRODUCTS FOR HUMAN USE
Part 207; REGISTRATION OF PRODUCERS OF DRUGS AND LISTING OF DRUGS IN COMMERCIAL DISTRIBUTION
Part 208; MEDICATION GUIDES FOR PRESCRIPTION DRUG PRODUCTS
Part 209; REQUIREMENT FOR AUTHORIZED DISPENSERS AND PHARMACIES TO DISTRIBUTE A SIDE EFFECTS STATEMENT
Part 210; CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PROCESSING, PACKING, OR HOLDING OF DRUGS; GENERAL
Part 211; CURRENT GOOD MANUFACTURING PRACTICE FOR FINISHED PHARMACEUTICALS
Part 212; CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS
Part 216; PHARMACY COMPOUNDING
Part 225; CURRENT GOOD MANUFACTURING PRACTICE FOR MEDICATED FEEDS
Part 226; CURRENT GOOD MANUFACTURING PRACTICE FOR TYPE A MEDICATED ARTICLES
Part 250; SPECIAL REQUIREMENTS FOR SPECIFIC HUMAN DRUGS
Part 290; CONTROLLED DRUGS
Part 299; DRUGS; OFFICIAL NAMES AND ESTABLISHED NAMES

Atsiliepimai

  • Atsiliepimų nėra
0 pirkėjai įvertino šią prekę.
5
0%
4
0%
3
0%
2
0%
1
0%
(rodomas nebus)